Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists.

MLA

Glatzer, Markus, et al. “Stage III N2 Non-Small Cell Lung Cancer Treatment: Decision-Making among Surgeons and Radiation Oncologists.” Translational Lung Cancer Research, vol. 10, no. 4, Apr. 2021, pp. 1960–68. EBSCOhost, https://doi.org/10.21037/tlcr-20-1210.

APA

Glatzer, M., Leskow, P., Caparrotti, F., Elicin, O., Furrer, M., Gambazzi, F., Dutly, A., Gelpke, H., Guckenberger, M., Heuberger, J., Inderbitzi, R., Cafarotti, S., Karenovics, W., Kestenholz, P., Kocher, G. J., Kraxner, P., Krueger, T., Martucci, F., Oehler, C., … Putora, P. M. (2021). Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists. Translational Lung Cancer Research, 10(4), 1960–1968. https://doi.org/10.21037/tlcr-20-1210

Chicago

Glatzer, Markus, Pawel Leskow, Francesca Caparrotti, Olgun Elicin, Markus Furrer, Franco Gambazzi, André Dutly, et al. 2021. “Stage III N2 Non-Small Cell Lung Cancer Treatment: Decision-Making among Surgeons and Radiation Oncologists.” Translational Lung Cancer Research 10 (4): 1960–68. doi:10.21037/tlcr-20-1210.